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ABSTRACT 
Albert Horsfall Medical Center (AHMC) is one of the first 25 centers that started the 
national Antiretroviral Therapy (ART) Program in Nigeria in 2001. The facility had 
162 registered patients and 109 of them were on anti-retroviral drugs at the time of the 
study. The aim of the study is to determine the characteristics associated with ART 
adherence, in Albert Horsfall Medical Center (AHMC), Abuja, Nigeria. The 
objectives are to measure the adherence to ART; assess the association of the 
demographic characteristic of patients on ART with adherence to medications in the 
facility; and to establish patients’ perspectives to adherence and impediments to 
compliance to ART in the center. The cross-sectional study of people living with HIV 
(PLHIV) receiving ART employed the use of self-report questionnaires, document 
review (pharmacy and clinical records) and the measurement of the current CD4 
counts and viral load of patients (biological measure).  Eligibility for participation as a 
respondent was limited to adult PLHIV who have been receiving ART in the facility 
in accordance with the Federal Ministry of Health (FMOH) ART guidelines for one 
month or more. Pretested questionnaires were administered to eligible persons by 
trained interviewers and blood taken for CD4 and viral load tests. The data was 
analyzed using EPI Info 2000 computer package. Results showed that 93.9% of 
respondents were reported to be adherent to the regimen and socio-demographic 
characteristics of the respondents namely age and marital status were not predictive of 
adherence. However, the adherence rate was not validated by the viral load test, as 
only 13.6% of the adherent group had no virus detected in their blood sample. 
Interventions should be implemented to improve patients’ adherence, and a follow-up 
study should be done to assess the outcomes of such interventions. 
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Topic: AN ASSESSMENT OF FACTORS ASSOCIATED WITH ADHERENCE TO 
ANTIRETROVIRAL THERAPY IN ALBERT HORSFALL MEDICAL CENTER, 
ABUJA, NIGERIA 
 
1.00 INTRODUCTION 
The majority of the 42 million people living with HIV/AIDS in the world are in Sub-
Saharan Africa (28 million); and Nigeria contributes more than 3.5 million adults to 
this figure (FMOH, 2004). Public health indices of Nigeria portray a precarious 
condition in terms of health, education and social indicators. It is known that 2 of 
every 3 (66%) Nigerian live below the national poverty level, Less than half (49%) 
has access to potable water and only 41% has access to adequate sanitation; and the 
situation is compounded by the fast growing multi-faceted impacts of HIV/AIDS 
(UNDP, 2002).  It is vital to urgently reverse the trend of the epidemic. 
 
 Nigeria is showing commitment in combating the epidemic through a multi-sectoral 
approach by the National Action Committee on AIDS (NACA). With the Federal 
Ministry of Health (FMOH), NACA formulates and implements policies that provide 
care and support for PLHIV in Nigeria. Of all activities, the most potentially 
rewarding is the provision of antiretrovirals (ARVs) for clinical management, 
prevention of mother to child transmission (PMTCT) and post exposure prophylaxis 
(PEP). Of the estimated 300,000 to 700,000 that require ARV, 13,433 adults as at 
mid-2004 (excluding private initiatives) have access to the drugs through 25 
government owned medical facilities (FMOH, UNAIDS, 2004). It has been projected 
that about one million will require ARV by 2009 (Miles et al, 2006). Albert Horsfall 
Medical Center is one of the 25 sites offering the drugs. While the program has been 
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expanded beyond the 25 sites, problems of adherence and emergence of resistant 
strains to the first line drugs remain a cause for concern. 
 
AHMC, a government owned primary health medical center is located at Garki 
District in the center the Abuja metropolis, has 162 patients registered in the clinic 
and 109 of them were on anti-retroviral medications at the time of the study.  Patients 
that were not listed to be on ARV drug were not qualified to commence the 
medications, deceased or lost to follow-up. There are five nurse counselors that 
undertake routine counseling, which includes pretest, posttest and adherence 
counseling on clinic days. Additionally, on every visit at the point of drug collection, 
the pharmacist is also required to counsel each patient on adherence. 
 
 The study which used self-report questionnaire administration, biological measures 
of CD4 count and viral load and review of the pharmacy log book, sets out to describe 
the demography and the adherence of patients as well as the realities of lapses in the 
implementation of anti-retroviral therapy program, primarily peculiar to Albert 
Horsfall Medical Center with a view to improving services.  
 
2.00 LITERATURE REVIEW 
2.01 Preamble: The literature review addressed the following issues: Models of care 
for ART service delivery, HIV epidemic in Nigeria, the level of non-adherence in 
ART, the demographic characteristics of non-adhering patients, adherence facilitators 
and barriers, interventions to improve adherence, methods to measure adherence and 
identification of gaps in knowledge. 
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2.02 Models of ART Services: 
Models of care for ARV service delivery have been well documented by Pienaar, 
Mayer & Cleary et al (2006) who in the report of a research into ART services in 
Western Cape, South Africa identified several models. These models are generally 
grouped into facility-based, community-based and individual care services. The 
facility-based models are basically vertical disease services programs, while 
community-based programs are services that employ the services of counselors 
(usually PLHIV) who operate in the communities and refer people appropriately to 
designated treatment point(s). Individual care provider service is a service provided 
by private practitioners (D. Pienaar, Myer, Cleary et al, 2006). The vertical programs 
are usually physician oriented, however due to the low physician-population ratio in 
most low resource settings, models lead by other medical personnel such as nurses, 
clinical officers and counselors are becoming common (Miles, Clutterbuck, Seitio et 
al, 2006).  
 
2.03 HIV Epidemic in Nigeria and FCT: 
Since the first case of AIDS in Nigeria was reported in 1986, the prevalence in 
Nigeria among pregnant women attending antenatal clinics has consistently grown 
from 1.8% in 1991 to 5.8% in 2001. The national mean prevalence for 2003-sentinel 
survey is 5.0% (FMOH, 2004). More than 3.5 million adults were estimated to be 
living with HIV in Nigeria in 2001 (FMOH & UNAIDS, 2004). Though the 2003 
mean prevalence stands at 5.0%, experts agree that the epidemic has not stabilized, as 
the prevalence was more than 10% in some communities. AHMC is situated in Abuja, 
the capital of Federal Capital Territory (FCT). The mean prevalence in FCT has risen 
in consonance with the national scenario from 7.2 % in 1999 to 10.2% in 2001; 
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however, the 2003 figure of 8.4% is higher than the national mean (FMOH, 2004. & 
2005).   FCT had the third highest HIV prevalence of the states in Nigeria in 2003. 
 
2.04 Non-adherence and its implications: 
Non-adherence is a major deterrent to a successful ART program. With the launching 
of the “3 by 5” initiative in 1st December 2003, Nigeria targeted ARV coverage of 
300,000 by the end of 2005. There is anxiety over the ability of the program to 
maintain good adherence. The benefits of appropriate ART adherence are well known 
to include sustained viral suppression, recovery of immune system (increased CD4 
count), experiencing less opportunistic infections, attaining a better quality of life, 
increased productivity, decreased HIV related mortality and increased life expectancy. 
Conversely, poor compliance is a recipe for the development of drug resistance, viral 
rebound, decline in health, development of opportunistic infections and rapid 
advancement to AIDS (FMOH, 2005).  
 
Adherence in a medical sense simply means the measure of the total compliance of a 
patient (whether self motivated or service assisted) to a health related regimen or 
instructions. About 50% of patients across a wide range of medical conditions are 
non-compliant; and 80% compliance is generally accepted as ideal in chronic diseases 
(Levine, 1998). Vanhove and colleagues (1996) reported increased viral load within 
days of ARV drug holiday in patients who had initially attained viral suppression  
(Cinti, 2000), therefore ART requires more adherence for optimal effect. Further 
clarification is realized when considering the study by Patterson et al. (2000), who 
reported that with 95% adherence to regime, 78% of patients achieved undetectable 
viral load; with 80 – 94 % adherence, 49% of the patients will attain undetectable 
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viral load and below 80% adherence, only 20% of patients will attain undetectable 
viral load. The conclusion therefore is that adherence to ART below 95% would most 
likely not produce complete suppression of HIV viral replication.   
 
2.05 Results of Adherence/adherence interventional measures: 
2.051 The Magnitude of Non-adherence:  
Highly Active Antiretroviral Therapy (HAART) implies the use of a combination of 
at least three drugs from at least two classes of ART.  Due to pill burden, pill fatigue, 
side effects and intricacies of dosing, adherence is difficult to achieve in HAART. 
Kumarasamy (2003) after a literature review numerated several factors that have been 
associated with non-compliance following literature review. The review identified 
patient’s knowledge of the disease, duration on medications, complexity of treatment, 
social support available to patient and patient’s perceived benefits as some of the 
factors. Additionally, relationship between patient and service providers, depression, 
alcohol and substance abuse, and self-efficacy were also listed as factors that may 
influence compliance of patient on antiretroviral medications in the same review. In 
another literature review by Chesney and colleagues (2000), estimates of HIV 
medication non-adherence ranged from 50% to 70% (Jones, 2001). A review of 
adherence to ARV drugs in a variety of care settings in San Diego, California 
revealed that 28% of patients had poor adherence (<80%), 23% of the patients adhere 
to the regime fairly (80% to 90% adherence) and 50% of patients adhered 
appropriately to their medications (>90% to 100%) (Gifford, Bowmann, Shiverly et 
al, 2000).  
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Some studies in Sub-Saharan Africa have demonstrated exceptionally high adherence 
rates above 90%. Laniece, Ciss, Desclaux et al (2003) in an observational prospective 
cohort study of Senegalese adults had a mean adherence of 91%.  Similarly, Orrell et 
al (2003) reported a mean adherence of a semi-urban, HIV-infected ART naïve South 
African cohort (CTAC- Cape Town AIDS cohort) up to 48 weeks of medication, to be 
93.5%.  A study done in Botswana showed relatively lower adherence. In a cross 
sectional study using a self-report questionnaire, 54% of the patients were adherent.  
As in the other two African studies, the major barrier to adherence was financial 
constraints (44%).  After removal of cost (the main predictor for adherence) using 
logistic regression, predicted adherence increased from 54% to 74% (Weisser, Wolfe, 
Bangsberg et al, 2003). 
 
2.052 Facilitators & Barriers: 
(a) Patient Related (Demographic) Factors: 
The review of several studies on adherence to antiretroviral drugs has shown that 
generally, demographic characteristics such as age, sex, income, education and 
employment status are not predictive of adherence (Petterson et al (2000); Bersh 
(1999); Orrell et al (2003); Laniece et al (2003). However, a few reports have shown 
some associations between demographic factors and adherence. Singh et al (1999) 
reported that non-whites are more likely than whites in USA to be less adherent (OR= 
22.5, P+0.013) and Pinheiro (2002 and Monreal et al (2002) found education to be 
predictive of the level of adherence in patients on ARVs in Brazil. Orrell and 
colleagues (2003), while agreeing that low socio-economic status is not associated 
with poor adherence in a South African study (the drugs were free), reported 
increasing age and speaking the same language with the service providers to correlate 
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with improved adherence and virologic out comes. Weiser et al (2003) reported 
similar findings from Botswana. The Senegalese study by Laniece et al (2003) and the 
aforementioned study in Botswana highlighted costs of medication and insurance 
coverage issues as reasons for gaps in treatment.   
 
 Forgetfulness is the most frequently cited of all reasons given by patients for poor 
compliance (Holzemer et al, 2000; Kumarasamy, 2005; Montreal et al, 1990; Chesney 
et al, 2000). Levine 1998 acknowledged that forgetfulness is more profound when 
patients’ routine has been disrupted as in travelling or even on weekends. 
Forgetfulness in absence of neuro-psychiatric impediments may be viewed as a 
marker for the totality of social support, psychosocial influences, trust in the service 
and patient’s met expectations by the therapy. It may be a pointer to an underlying 
social problem or a sign of service inadequacy.     
(b) Psychosocial influences on the patients may constitute the most important group 
of factors affecting adherence in the presence of adequate access to ART (Cinti, 2000; 
Besch, 1995; Singh et al 1996). These concerns, such as patient’s understanding of the 
disease and regimen and reasons for taking each medication may have profound effect 
on adherence (Daar et al, 2003).  Additionally the patient’s attitude, cultural and 
health beliefs, coping skills and trust in the therapy and the medical establishment 
ought to be positive, in order to attain reasonable adherence. More specifically, the 
degree to which antiretroviral efficacy meets patients’ expectations affects adherence; 
such met expectations motivate very sick patients to attain high adherence rates. The 
level of motivation, existing stress, active substance abuse and the level of self-
efficacy of patients, all affect drug adherence (Daar et al, 2003).  Wenger and 
colleagues found that heavy alcohol and drug users significantly adhere less than 
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nonusers (Cinti, 2000). Though this assertion agrees with reports from some other 
studies, not all studies are consistent, especially regarding injection users.  
 
(c) Health Care related factors that may affect adherence are physician-patient 
relationship, the presence of ‘significant other’, presence of a supportive care provider 
and support peer group (Levine, 1998; Pinheiro et al, 2002).  While the use of 
multidisciplinary services- the “one stop shopping approach” - improves adherence, it 
has been recognized that a strengthened referral system, simple regimen (number of 
pills, frequency of dosing and food conformity) all affect adherence (Cinti, 2000; 
Eldred et al, 1998). Orrell et al further acknowledged that three times daily therapy 
was the strongest predictor for both poor adherence and virologic failure in a 
multivariate analysis; and that the best improvement in adherence comes with the 
reduction of dosing frequency from three to two times a day. Brigado et al noted 
interestingly that in Brazil, naïve patients were less compliant, however adherence 
seems to improve as treatment progresses.  Another dimension was introduced, when 
Lanciece et al reported higher adherence in Efaverenz-containing regime than 
indinavir-containing regimens, a result that may be related to pill burden and side 
effects. 
 
 
2.06 Adherence Interventional Measures:  
Directly observed treatment (DOT) may not be easily achieved in antiretroviral 
therapy. Addressing psychosocial, demographic and health factors that affect 
adherence are the hallmark of adherence enhancement (Romanelli & Pomeroy, 2000). 
Improving adherence should be proactively done through identification of possible 
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barriers during counseling and planning how to appropriately address them before the 
first drug prescription is made. Reviews by some authorities have recognized some 
strategies that may be included in developing an adherence improvement program 
(Cinti, 2000; Daar, Cohen, Remien et al, 2003; Levine, 1998).  Such strategies include 
those that encourage close patient-provider contact, social support and education, 
treatment of co-morbid conditions and anticipating problems that may promote non-
compliance. Also, regimen rehearsal, simplifying regimen and use of pill organizers 
are other interventional measures that may improve adherence.  
 
2.07 Study Design and Methods in Measuring Adherence to Antiretroviral Therapy: 
Though the majority of the initial studies employed clinic based quantitative designs 
(chiefly cohort and cross-sectional), qualitative studies are becoming popular, 
especially in action-oriented research of health systems (Kumarasamy et al, 2005 & 
Stone et al, 1998). Studies by Kumarasamy (2005) and Stone (1998) assessed 
knowledge and awareness of ARVs, experience taking ARVs and adherence to ARVs 
using qualitative methods. Stone et al had six focus group interviews in ART patients 
from three teaching hospitals and two community health centers, while Kumarasamy 
and colleagues used in-depth interviews of 60 patients receiving primary care in an 
NGO to gather their data.  
 
The available methodologies cannot measure adherence with certainty, therefore more 
than one method is usually used in studies; and often complimented with a surrogate 
marker such as viral load or the cheaper option of CD4 count to gauge the ability of 
these methods to measure adherence (Cinti, 2000; Harrigan et al, 2005; Murri et al, 
2004). Cinti further stated clearly that outside DOT (Directly Observed Treatment), 
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there is no “gold standard” for adherence and that though DOT is being advocated for 
in recent times, it appears impracticable in antiretroviral therapy, because it is difficult 
to directly observe patients over long periods of time. Levine (1988) summarized the 
methods used in assessing compliance with advantages and disadvantages inherent in 
each method to include self-report (SR), provider assessment, pill count, Medical 
Electronic Monitoring System (MEMS) and the use of biological monitoring systems.    
 
 
SR has been used in several studies because of its simplicity in practice 
(Kumarasamy, 2005; Murri et al 1998 & Safren et al, 2005) though it has the inherent 
tendency to overestimate compliance (Sackett et al, 1975).  Nevertheless, Cinti, S. K. 
(2000) noted that the accuracy of SR as a tool might be improved by careful wording 
of the question to formulate specific and non-judgmental inquiry. Additionally, 
complimenting with pill counts, biological measures and pharmacy log may improve 
its validity (Demasi, Tolson, Pham et al, 1999; Chesney 1997; Haubrich, Little, 
Currier et al, 1999; Gifford, Bormann, Shiverly et al; 2000). Laniece et al (2003) used 
SR, viral load and pill count in their study. The mean adherence (91%) was validated 
to some extent by expected high viral load in less adherent patients; nevertheless the 
level of false positive adherence results may still be significant. In a cross sectional 
study in Brazil, 57% of patients reported less than 95% adherence, which was much 
lower than reports from other parts of Brazil, although the use of SR in the study was 
validated by the demonstration of a significant association between viral load below 
500 copies/ml and good adherence (Pinheiro et al 2002).  
2.08 Evaluation of the knowledge: 
The literature review has revealed that optimal benefits of antiretroviral therapy can 
only be achieved at appropriate levels of adherence. Furthermore, studies have shown 
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that adherence is underpinned by a myriad of barriers and facilitators that come into 
play in different magnitudes, depending on the socio-economic, psychosocial and 
cultural environment. It is therefore pertinent to search for factors that are peculiar to 
the organization concerned, prioritize them, and intervene in accordance to the most 
pressing and feasible needs of the organization, while recognizing individual patient’s 
needs. The essence of the research, time and resources (financial, manpower and 
material) available for the study, are all factors that may affect the design and tools 
chosen in a given circumstance. 
 
Literature available to the author has indicated a relative paucity of studies on 
adherence to antiretroviral medications in Nigeria, though antiretroviral drugs have 
been in use officially since 2002. There is a need to investigate what factors may exist 
in different localities in Nigeria, that may affect ART adherence. Issues such as 
adherence patterns, factors associated with non-adherence, effect of poor adherence 
on the success of ART, the level of resistance to antiretrovirals and monitoring of 
adherence interventional programs should be examined, in the context of the customs 
and culture of the people. At present the expected behavior of HIV positive patients 
and service providers are projections from experiences exogenous to the Nigerian 
environment. The need to gather local evidence and to develop evidence based 
options in antiretroviral management has never been greater, especially with the need 
to scale up coverage. 
 
Due to limited logistics and time available to the researcher, the study concentrated on 
the users of the facility. Triangulation of methods of data collection was undertaken to 
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increase the validity of the quantitative data. Results from this study were used to 
formulate and recommend interventions for improved ART adherence in the facility.  
 
3.0Aim and Objectives 
3.01 Aim: To determine which factors affect adherence to ART among HIV positive 
patients in Albert Horsfall Medical Center (AHMC). 
3.02 Objectives: 
I. To measure the adherence to ART in patients attending AHMC. 
II. To assess the association of demographic characteristics of patients on ART 
with adherence to HAART in AHMC. 
III. To explore AHMC patients’ perspectives on facilitators and barriers to 
adherence to ART. 
 
4.00 METHODOLOGY: 
4.01 Design: A written approval of the study by the management of the facility was 
obtained before the commencement of the research. Additionally, stakeholders 
involved in the study were informed of the fact that the study is a part requirement for 
the award of an MPH degree to the researcher by The University of the Western Cape, 
Republic of South Africa.  
 
The research was a cross sectional study using self-report (SR) questionnaires, 
complimented by document review (clinical and pharmacological records) and 
biological measures (CD4 count and viral load) of each participant.  
 
4.02 Population of study and eligibility: The population of study consisted of adult 
PLHIV receiving antiretroviral therapy in AHMC. Eligibility of participants included 
adult PLHIV who met the FMOH criteria for ART in Nigeria, which include patients 
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with WHO stage IV disease (irrespective of CD4 count), WHO stage III disease with 
CD4 count less than 350/mm3, and stage I & II disease with CD4 count of 200/mm3 or 
less. Also, patients must have been receiving antiretroviral drug treatment in Albert 
Horsfall Medical Center for at least one month. This was to ensure that both short 
term and long-term hindrances to adherence are assessed and that the participants had 
some measure of experience with the medications. All adults who are on ART in the 
facility were to be included due to the relatively small size of the population of study, 
however eight persons declined participation in the study and three did not attend the 
ART clinic through out the period of data collection (July – October 2007). A total of 
98 persons participated in the study.  
 
4.03 Procedure: Structured interviews using pre-tested 27-question questionnaires 
were administered to patients receiving ARVs in AHMC. On the same day blood was 
taken from respondents and forwarded to the laboratory for CD4 count and viral load. 
The present CD4 count and viral load levels of the participants were used to assess the 
validity of the self-report adherence levels reported by the participants. Information 
collected using the questionnaires included the demography of patients receiving ART 
in the facility, knowledge of the disease and the therapy, estimation of adherence, 
facilitators and barriers to ART adherence and the desired changes to the ART service 
from the patient’s perspective. Clinical and pharmacy records were reviewed in order 
to assess adherence and provide other information needed for the further analysis of 
data.  
4.04 Analysis:  Computer analysis of the data was done using Epi Info 2002 statistical 
software. In calculating the mean adherence level, the statistical test used was a t-test 
for a single mean, since we were dealing with one sample. In relating the mean to the 
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different demographic and operational strata in the study, PLHIV was categorized into 
adherent and non-adherent groups. Since more than 5 respondents was expected per 
cell, Chi squared for association (2-by-2 table) was utilized to test for statistical 
significance. Missing more than one dose in a week was considered non-adherence, 
irrespective of the drug combination regime of the patient. Most patients are on first 
line treatment which entails the use of a combination of nevirapine, stavudine and 
lamivudine; each taken twice a day, and a patient is required to take 14 combined-
drug doses in a week. Adherence was defined as taking 13 combined-drug doses 
(92.85% in take of medications) in a week.   
 
4.05 Consent:  Consent was obtained by writing to each participant and requesting for 
participation. Detailed information regarding the study was given in the letter. The 
attending nurses explained the contents of the letter to each participant during routine 
clinic days, before handing the letters to participants. For clients who provided 
informed consent to participate in the study, interviews were scheduled with a trained 
interviewer. Participants were reassured that participation was voluntary and that 
refusal would not affect their treatment in the center, and that they had the liberty to 
withdraw from the research at any time if they so desired. Similarly, such withdrawal 
would not affect their status as patients in the center.  The benefits of the study were 
explained to them. They were further informed that the true identity of participants 
and their individual test results will be kept confidential and the report of the study 
will not reveal the identities of participants. A stipend (fixed amount of money) was 
given to each participant to assist his or her transportation to the center after the 
interview following approval of the participant. . 
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4.06 Validity/ Reliability & Generalisability:  The strength of the study lies in the 
triangulation of data collection methods. The use of multiple sources of information 
should provide corroborative evidence thereby strengthening the validity of the study. 
All patients on ART in the facility who consented were admitted as participants due to 
the small sample size of the population of study. Additionally, interviewers received 
one and a half hours per day training for 5 days, on the conduct of face-to-face 
interviews. These measures increased the reliability of the study. Medical worker 
interviewers comprising of two dental nurses, one theatre nurse and a general duty 
nurse were not involved in the management of these patients in the center so as to 
minimize information bias. Interviews were conducted in a quiet room with only the 
interviewer and the respondent in attendance. No participant needed an interpreter as 
all the interviewers could communicate in the languages spoken by participants 
(Hausa, English or “pidgin” English). All interviewers were fluent in the three 
languages. This improved the validity of the study. 
  
Reliability was further enhanced through the pre-testing of the questionnaires to 
ensure questions are clearly worded and easily understood. Trained interviewers 
interviewed twelve patients selected from a similar ARV center within Abuja city that 
is participating in the national antiretroviral program. Selection of respondents for the 
pretest exercise covered both sexes from 20 to 45 years of age. After the pretest, the 
questionnaire was discussed by the researcher and the interviewers then amended 
accordingly. Also, the same interviewers conducted the pre-testing exercise and 
administered the final questionnaires to research participants. Additionally, double 
entry of data was done to reduce typing error (two people entered the data using 
different computers and areas of disagreements were considered and resolved by the 
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two persons). Outliers were eliminated before the actual analysis of the data using the 
list command in Epi Info 2002. 
 
Generalizability of data may be limited to other PLHIV within Abuja metropolis 
receiving free antiretroviral drug therapy under the FMOH program in similar primary 
health centers. Conditions surrounding clinical care and support may be different in 
other parts of Nigeria and elsewhere.   
 
5.00 Results:  The total number of patients on anti-retroviral therapy in Albert 
Horsfall medical Center is 109 and all were targeted to participate in the study. Of this 
number, 98 persons consented and participated in the study (response rate of 89.9%). 
Three of the patients who did not participate did not attend the clinic within the four 
months period from July to October, when data was collected; and eight eligible 
persons declined participation for various reasons. Using Epi info 2002 in the analysis 
of the data, the characteristics of the respondents were computed and the results are as 
follow: 
 
5.01 Demographics: The respondents were all adults with 43.9% of them being male, 
and 56.1% of them females.  The age of the respondents ranges from 21 to 58 years 
with the average age being 36.6 (SD = 8.2). The majority of men (79.1%) were 
between 31 and 50 years old while the majority of women (78.2%) wee between 21 
and 40 years old (Table 1). The average respondent was married (64.9%), had a 
tertiary education (44.8%), was employed (71.9%) and worked full time (56.90%).   
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The majority of workers earn between 10,000 and 40,000 Naira (79 to 317 USD) per 
month (51.4%), while 27.1% earned less than 10,000 Naira per month. 57.7% were 
head of their household; and of the 42.3% who were not head of their household, 
43.9% did not know the salary range of the head of their household; and 31.7% 
indicated that the head of their household earned between 10-14,000 Naira. Though 
the majority of them earned poorly, 75.5% indicated that they have never missed their 
appointment because they could not afford to pay for transportation, while 24.5% had 
indicated that the had missed a clinic appointment because they could not afford 
transportation fare to the ARV clinic. Information on socio-demographics obtained 
during the study has been collapsed into categories and presented in Table 1. 
 
5.02 Understanding the use of ART and regimen: Assessing the understanding of 
regimen was done during the interview by asking the respondents to describe how 
they take their medicine, then specific elicitations were made to fill in respondents’ 
understanding of the number of drug in the combination therapy, dosages of 
medicines at initiation of therapy, dosages at the time of interview, knowledge of 
common side effects and any interaction with food. Each aspect was given a point if 
answered correctly and the total points were graded into excellent, good, fair, poor 
and no understanding categories. It was found that 89.6% of the respondents had a 
good to excellent understanding of the anti-retroviral drug regimen, while 4.2% and 
6.2 % had poor and fair understanding of the regimen, respectively. Regarding the use 
of ARV medicine when used as prescribed by persons who are HIV positive, 87.6% 
indicated that the therapy reduces the number of HIV in the body; 4.1% believed the 
drugs cure HIV, while 1.0% believed that the medicine cures TB and 7.2% did not 
know the effect of ARV on the body. 
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Table 1: Demographics of patients on ART in AHMC: 
 
5.03 Facility service provision: In assessing the acceptability of the services rendered 
at the center, respondents were asked whether they would advise a close relative who 
has tested positive to HIV to enroll for treatment in the center. Most (80.4%) 
answered that they would, 12.4% said they probably would, while the choice of 
‘never’ and ‘probably not’ options contributed 2.1% and 5.2% respectively. Of the 98 
respondents, 88.8% had confided their HIV status in another person against 11.2% 
who had not as of the time of the interview. There was a preponderance of patients 
who had access to any of the clinic’s staff by phone (61.2%) over those who had no 
phone access (38.8%). Additionally, 61.9% of those with phone access indicated that 
it was easy to contact the clinic’s staff, against 28.6% who never had the need to call 
any member of the clinic. Regarding the stock of anti-retroviral drugs in the facility, 
Characteristics Men (n= 43) 
n (%) 
Women (n = 55) 
n (%) 
Total (n = 98) 
n (%) 
Age  
  21 – 30 
  31 – 40 
  41 – 50 
  51 - 60 
 
7 (16.3%) 
18 (41.9%) 
16 (37.2%) 
2 (14.7%) 
 
21 938.2%) 
22 (40%) 
10 (18.2%) 
2 (3.6%) 
 
28 (28.6%) 
40 (40.8%) 
26 (26.5%) 
4 (4.1%) 
Marital status 
 Married 
 Divorced 
 Separated 
 Widowed 
 Single  
 
31(72.1%) 
0 (0%) 
2 (4.7%) 
1 (2.3%) 
9 (20.9%) 
 
32 (59.3%) 
5 (9.8%) 
2 (3.7%) 
7 (13.0%) 
8 (14.8%) 
 
63 (64.9%) 
5 (5.2%) 
4(4.1%) 
8 (8.2%) 
17 (17.5%) 
 
Education  
 Never 
 Primary 
 Secondary 
 Tertiary  
 Post-graduate 
 
0 (0%) 
5 (11.9%) 
12 (28.6%) 
21 (50%) 
4 (9.5%) 
 
3 (5.6%) 
3 (5.6%) 
24 (44.4%) 
22 (40.7%) 
2 (3.7%) 
 
3 (3.1%) 
8 (8.3%) 
36 (37.5%) 
43 (44.8%) 
6 (6.2%) 
 
Employment status 
 Employed 
Not employed  
 
36 (85.7%) 
6 (14.3 %) 
 
33 (61.1%) 
21 (38.1%) 
 
69 (71.9%) 
27 (28.1%) 
 
Monthly income 
  <10,000 
  10-40,000 
  41-80,000 
 81-160,000 
   
 
7 (18.4%) 
20 (51.6%) 
9 (23.7%) 
2 (5.3%) 
 
12 (37.5%) 
16 (50.1%) 
3 (9.4%) 
1 (3.1%) 
 
19 (27.1%) 
36 (51.4%) 
12 (17.1%) 
3 (4.3%) 
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an overwhelming proportion of the participants (93.9%) had never experienced the 
pharmacy not being able to replenish their stock; and the remaining 6.1 % said the 
pharmacy rarely run short of anti-retroviral drugs.  
 
Table 2 shows that 74.5% of the respondents did not feel that changes should be 
effected in the way the clinic is operating presently. The others (25.5%) feel that 
changes should be made as presented in the following proportions of the total number 
of participants: 3.1% of the respondents want improved confidentiality, 3.1% seek to 
increase the number of clinic days, 2% require the clinic to improve its laboratory 
services, one needed welfare packages to be added to clinical services and 9.2% 
advocated for improved time management and reduction of patient waiting time. 
 
Table 2: The need for changes in the clinic 
Changes in 
Clinic  
Frequency Percentage Cum percent 95% C I 
Yes 
No 
Total 
25 
73 
98 
25.5% 
74.5% 
100% 
25.5% 
100% 
17.2% - 35.3%
64.7% -82.8%
 
 
5.04: Adherence to ARV medication: The proportion of participants who reported not 
missing any dose in the past one week was 85.7%, while that of those who missed one 
dose over the same duration of time was 8.2%. Defining adherence in this study as not 
missing more than one dose within one week, 93.9% (CI 87.1%, 97.7%) of the 
participants were adherent. 
 
Table 3: Missed doses 
Doses missed in a 
week (adherence) 
Frequency Percentage Cumulative 
percentage 
95% CI 
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0 (100%) 
 
1 (92.85%) 
 
2 (85.72%) 
 
3 (78.57%) 
 
4–14 (71.43 – 0%) 
 
Total 
84 
 
8 
 
3 
 
1 
 
2 
 
98 
85.7% 
 
8.2% 
 
3.1% 
 
1.0% 
 
2.0% 
 
100% 
85.7% 
 
93.9% 
 
96.9% 
 
98.0% 
 
100% 
77.2% - 92.0% 
 
3.6% - 15.5% 
 
0.6% - 8.75 
 
0.0% - 5.6% 
 
0.2% - 7.2% 
 
 
The respondents gave various reasons for missing dose(s). Forgetfulness was the 
commonest reason given for missing doses (5.1% of all the respondents). The other 
reasons include ignorance and traveling represented by 2.9% and 4.1% answers from 
the respondents respectively.  The reasons given for remembering to take the drugs 
regularly were also varied. The most common reason (44.9%) was the use of alarms, 
cell phones or other time devices; 33.7% believe that they remember to take the 
medicine because the drugs have become part of them or routine and habit; 16.3% 
attributed it to sustained social support and education, and 9.2% cue the drug intake 
with other activities such as meals. A minor proportion (2%) indicated fear of dying 
as a major remainder to take their drugs. 
 
A univariate analysis of the demographic characteristics in association with adherence 
level of the research participants using data from the self-report interviews only, has 
shown that there was high adherence in each category of the different demographic 
characteristics of the samples namely: gender, marital status, educational status, age 
category and monthly earnings. Adherence rates for the males and females were 
97.7% and 90% respectively, while marital status categories had rates of between 90 
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and 100%. The characteristics of the sample of study as related to adherence level are 
summarized in Table 4. 
Figure 1: Percentage of adherent & Non-adherent in the sample. 
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Table 4 Associations of socio-demographics with adherence: 
Characteristics  Adherence 
0 – 1 misses/wk 
n (%) 
Non-adherence 
2 – 14 misses/wk 
n (%) 
Total  
 
 
N  
Probability  
Gender  
 Male 
 Female  
 
42 (97.9%) 
50 (90%) 
 
1 (2.3%) 
5 (9.1%) 
 
43  
55  
Fisher’s exact 2-
tailed 
0.23 
Age 
 21 – 30 
 31 – 40 
 41 – 50 
 51 - 60  
 
26 (92%) 
36 (90%) 
26 (100%) 
4 (100%) 
 
2 (7.1%) 
4 (10%) 
0 (0%) 
0 (0%) 
 
28  
40  
26  
4  
Chi square linear 
trend 1.386 
P = 0.24 
Marital status 
 Married 
Not married 
 Divorced 
 Separated 
 Widowed 
 
59 (93.7%) 
32 (94.1%) 
4 (80%) 
4 (100%) 
8 (100%) 
 
4 (6.3%) 
2 (5.9%) 
1 (20%) 
0 (0%) 
0 (0%) 
 
63  
34 
5  
4  
8  
 
Fisher’s exact for 
2-tailed Married 
vs Not married 
P = 1.0  
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  Single  16 (94.1%) 1 (5.9%) 17  
Education 
 Never 
 Primary 
 Secondary 
Tertiary 
Post-graduate 
 
3 (100%) 
7 (87.5%) 
34 (94.1%) 
41(95.3%) 
6 (100%) 
 
0 (0.0%) 
1(12.5%) 
2 (5.6%) 
2 (4.7%) 
0 (0.%) 
 
3  
8  
36  
43  
6  
 
Chi square linear 
trend 0.372 
 P = 0.54 
Employment  
 Employed 
 Not employed 
 
66 (97.7) 
24 (88.9) 
 
3 (4.3%) 
3(11.1%) 
 
69  
27 
 
Fisher’s exact 2-
tailed  
0.39 
Monthly  
<10,000 
 10-40,000 
 41-80,000 
 81- 160,000 
 
18 (94.7%) 
35 (97.2%) 
12 (100%) 
2 (66%) 
 
1 (5.3%) 
1(2.8%) 
0 (0.%) 
1(33%) 
 
19  
36  
12  
3  
 
Chi square linear 
trend 0.608 
P = 0.44 
 
At initiation of therapy, records have shown that the CD4 count ranges from 14 to 520 
cells/ml. The average CD4 of participants was 206.2, the median at 196.5 (SD = 
100.86). The present CD4 count has a range of 22 to 859; with the mean and median 
being 301.2 (SD =164.6) and 266 respectively. The mean and the mode for the 
number of months respondents have been on anti-retroviral drugs are 32.6 months and 
30 months respectively. Duration of intake of drugs ranges from 1 to 93 months. 
Though there appears to be improvement between the median values of the initial and 
the present CD4 counts, a scatter plot graph of the change of CD4 counts from the 
baseline and the months on ARV in Figure 3 indicates a negative gradient. Tabulating 
the adherence status of respondents against CD4 in categories, the percentage of 
persons with CD4 count above 250 were 56.7% and 50% for the adherent and non-
adherent group respectively; only minimal difference noted. Though no person in the 
non-adherent group had a CD4 count within the range between 501- 1000, 50% in the 
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non-adherent group had CD4 count within the range of 251 – 500 against 45.6% for 
those that reported adherence to antiretroviral medicines. 
 
Figure 2: Scatter Plot of CD4 change from baseline and Months on ARV 
 
 
The results of viral load tests indicated that 93 results were valid and 5 invalid. 14% 
of the respondents had undetectable viral load count, while 86% had copies of viruses 
detected in their blood.  Comparing respondents’ adherence status with their viral load 
status using 2 X 2 table, only 13% in the adherence group had undetectable viral load 
and 86.4% in the same group had viruses detected in their blood (OR = 0.6316, Fisher 
exact 0.5374). Therefore the viral load did not validate the adherence rate of 93.9% as 
reported by the respondents.  
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5.05 Review of medical records: Albert Horsfall Medical Center started ART fully in 
January 2002 as part of the Federal Ministry of Health national anti-retroviral 
treatment program. The total number of patients registered in the center at the time of 
review was 162. A review of the registration book indicated that, of this number, 79 
are female, 84 are male, 10 (8 men and 2 females) are deceased, 3 were confirmed to 
have been transferred to another ARV center, and 4 persons were reported to have 
absconded. As the center caters for only adults, all pediatric patients are referred to 
other centers with pediatric antiretroviral therapy program within Abuja city.  
 
At present, the center runs its ARV clinic one day per week (specifically on 
Thursdays), while collection of medications; laboratory investigation and counseling 
services can be accessed by clients throughout the weekdays. On the clinic days, each 
patient goes through general counseling; clinical assessment and care; collection of 
drugs and adherence counseling; before getting an appointment for the next visit. 
Staff members involved in the ART clinic include the head of the program, three 
doctors, five nurse counselors, two pharmacists and one laboratory scientist.  There is 
no health information manager or a specific person charged with this responsibility; 
and the above staff members are also involved in other activities necessary for the 
day-to-day running of the center. 
 
From the initial 25 slots in 2002, the number of patients on antiretroviral drugs has 
grown gradually to 109 as of the time of this report. Review of the pharmacy log book 
over a period covering the last nine months revealed that 32 of the 109 nine patients 
(29.4%) had delayed or had not collected their drugs in the month of October 2007. 
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Similarly 41 of the 109 persons (37.6%) have failed or delayed to collect their 
medications at least once in the past nine months.  
 
6.00 DISCUSSION: 
6.01 Frequency of adherent respondents: The frequency of self-report adherence of 
the respondents to anti-retroviral drugs in this study is comparable to previous 
adherence studies carried out in Sub-Saharan Africa that equally demonstrated 
exceptionally high adherence rates. Laniece, Ciss, Desdaux et al (2003) reported a 
mean adherence of 91% following an observational cohort study in Senegal. An 
equally high frequency of adherence of 93.5% was reported in the CTAC (Cape Town 
AIDS Cohort) study at 48 weeks medication (Orrell, Bangsberg, & Wood, 2003). 
 
High adherence among the respondents in this study may be due to the over reporting 
inherent in self-report questionnaires as a method of data collection. There may have 
been some element of information bias, since the collection of data was done within 
the facility, even though by trained nurses who are not members of the ARV team in 
the facility. The cross-sectional study design using a self-report method of data 
collection may not be responsible for the high adherence recorded in AHMC as a 
similar research setting had recorded only 54% adherence among respondents in 
Botswana (Weisser, Wolf, Bangsberg et al, 2003). Nevertheless, in that study, 
removal of cost of ARV medications using logistic regression increased the predicted 
adherence from 54% to 74%. In AHMC, the drugs are free, therefore cost is not an 
issue when considering adherence. Free drug provision may be a major factor 
affecting adherence. Most patients could not afford to buy these medications on a 
consistent basis. 
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It may also be argued that there was a sample bias because the eight people that 
declined participation and the three that did not show up during the data collection 
may all be non-adherent patients. Addition of assumed non-adherent respondents 
(eleven in number) to the non-adherent group would bring the frequency of adherence 
to 84.4%; which is still an appreciable level of adherence.   
 
The frequency of self-adherence adherence (93.9%, CI 87.1 - 97.7%) could not be 
easily validated with the CD4 count increase following the initiation of antiretroviral 
drugs as different respondents had different durations of time on the medications. 
Although as expected, the mean CD4 count had increased from 206.2 cells/ml for the 
initial CD4 count before therapy initiation to 301.2 cell/ml at the present; the graph 
plotting months on ARV against present CD4 count change from baseline in Figure 3 
shows a resultant negative gradient. Possible explanations are the presence of resistant 
HIV to the first line drugs which the majority of the respondents are taking, high 
presence of co-morbid conditions or there is an over report of adherence in the study. 
Additionally, information from the pharmacy log has shown that over a period of nine 
months review, 37.6% of persons on ARV drugs delayed or failed to pick up their 
drugs when due; and in the month of October, 20.4% failed to pick up their drugs on 
time. This clearly points to the possibility of over reporting of adherence in the study, 
assuming that records in the pharmacy logbook are accurate. Viral load would be an 
appropriate biological measure to validate adherence barring the presence of virus 
resistant to ARV medications in use in the facility. Only 13% of the respondents had 
undetected viral load level despite a high self-report adherence rate by the majority of 
the respondents.  On further analysis, only 13.6% of those who reported adherent had 
viral load below the level of detection in their blood. This further gave the impression 
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of high self-report. Assuming that there was no overestimated self-report of 
adherence, then there may be high resistance to one or more of the first line 
antiretroviral medications in use.   
 
6.02 Association of adherence with demographic characteristics of the respondents: 
The frequency of adherence to ARV drugs was high in each category of the different 
socio-demographic characteristics in the sample of study. The characteristics of the 
respondents considered in the study are gender, marital status, education, employment 
status, monthly earnings and age. No categories of age, marital status, educational 
status and monthly earnings had statistically significant associations with adherence 
among the respondents. Several other studies found that no demographic 
characteristic was predictive of adherence (Patterson et al, 2000; Bersch, 1999; Orrell 
et al, 2003 & Laniece et al, 2003). A few studies, however, have found that some 
demographics were predictive of adherence. Sign et al (1999) noted that non-whites 
were less likely to adhere to ARV drugs regimen than whites in USA, while Pinheiro 
et al (2002) and Monreal et al (2002), found education to be predictive of adherence 
in Brazil.  
 
6.03 Service provision: The respondents appear pleased with the performance of 
facility in terms of the services rendered. 80.4% of respondents indicated that they 
would definitely advise a close relative to enroll in the clinic if tested positive for HIV 
and 12.4% agreed they would probably do the same. Furthermore, 74.5% of 
respondents did not feel that changes should be made in the way the clinic is 
operating. It should also brought to the fore that 89% of the patients had good to 
excellent understanding of the regimen, and 87.6% of the respondents had a good 
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understanding of the effect of antiretroviral drugs on the body when used by HIV 
positive persons. Also, the performance of the pharmacy department was rated very 
high - 93% of the respondents indicated that the pharmacy has never run short of 
medicine or delayed the replenishment of their stock of drugs, while 6% indicated that 
they rarely experience out of stock in their dealings with the pharmacy. These are 
indicators of patients’ satisfaction in the running of the clinic. However, information 
bias cannot be ruled out as the reason for such acceptability of the clinic’s 
performance. It is true that until the recent expansion of services, getting enrolled in 
the government’s national ARV program used to be difficult due to the fact that 
institutions were given slots they should not exceed, and these slots were gradually 
increased.  
  
There may be a need to intensify counseling and education of patients on some of the 
issues related to the management of HIV/AIDS. A situation where 14.6% of the 
respondents were assessed below average in the understanding of the regimen and 
12.6% did not know the use of the antiretroviral drugs needs to be corrected. In this 
regard, it is necessary for the staff of the ART clinic to embark on continuous 
education especially for counselors to enhance their present performance. Though 
44.9% use time devices to remind them to take their medications and 93.9% of the 
respondents consider themselves adherent to medications, there is a need to introduce 
more measures to aid adherence. Some of the pertinent changes that the respondents 
desired should be looked into and, where possible, meaningful changes should be 
made to improve confidentiality, increase clinic days, improve the laboratory services 
and reduce patient waiting time thereby improving on time management, in the 
running of the clinic. It is also important to improve on the phone access to the staff of 
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the clinic by making it mandatory that patients own a copy of a printout containing 
the phone numbers of some of the key staff members of the clinic. At present only 
62.2% have the phone number of at least one member of staff. 
 
7.0 Limitations of the study: 
1. Self-report (SR) was chosen because of its simplicity. SR has inherent ability to 
overestimate compliance. Some authorities however believe that with careful wording 
of the questions in a specific and nonjudgmental manner, its accuracy can be 
increased. We strived to achieve high accuracy in the formulation and administration 
of the questionnaires during the study. Nevertheless, overestimation of adherence may 
have occurred because the data collection was done within the facility. 
2. Secondly, records of patients were not well organized; hence extracting needed data 
was difficult and time consuming. This was not surprising, as no person has been 
trained specifically to manage data in the ART clinic. 
3. Results obtained are only applicable to the ART clinic in Albert Horsfall Medical 
Center and similar primary health centers in Abuja engaged in the provision of 
antiretroviral drug therapy under the national ARV program. 
 
 
8.0 Conclusion/Recommendations:  
1. The frequency of self-report adherence among patients receiving antiretroviral 
therapy in Albert Horsfall Medical Center is high (93.9%, 95% CI 87.1 – 
97.9). However, only a few patients attained the level of undetected viral load. 
2. Demographic factors were not associated with adherence in the study. 
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3. Patients were generally satisfied with the performance of the clinic. However, 
they observed that there is a need for changes to be made in the running of the 
clinic so as to address problems of confidentiality, time management and 
patient waiting time. They considered it necessary that the laboratory services 
should be improved; and additionally, the number of clinic days should be 
increased from the present one day per week. 
4. The following additional recommendations are made in order to improve the 
running of the clinic; 
• Counselors in the ARV team should have continuous education in 
adherence counseling  
• Counseling for adherence should be intensified and must be become a 
routine during drug collection and general counseling sessions. A drug 
adherence strategy should be developed for the clinic. 
• Health information manager should be employed or the clerk of clinic 
trained to take full responsibility of management of records in the ART 
clinic. 
•  Laboratory services should be improved to be able to carry out all the 
basic tests necessary for good follow up of patients including CD4 
count, which at present is conducted with the cost borne by patients 
outside the facility.  
• A conscious effort should be made to address some of the concerns 
raised by the respondents above, where feasible. The report of this 
research will be brought to the notice of the Director of medical 
services and the Head of the ARV team. 
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•  There is a need for a more comprehensive study of adherence and the 
ARV resistance profile in the Abuja metropolis as the national program 
is expanding. In this regard, the Ministry of Health in Federal Capital 
Development Authority should be informed of the outcome of the 
study in writing with a suggestion to partner with other agencies to 
carry out the a wider study.  
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Annex 1: Questionnaire 
QUESTIONNAIRE 
ON 
COMPLIANCE  ARV: Albert Horsfall Medical Center 
(All missing data will be coded 99, and non-response 88, other answers as coded) 
 
1. Questionnaire Number  ……….. 
2. Gender: 
[  ] male    1 
[  ] female 2 
 
3. How old were you on your last birthday? State in years………. 
 
4.  What is your marital status? Choose the most appropriate answer 
     [  ] married       1 
     [  ] divorced     2 
     [  ]  separated   3 
     [  ]  widowed    4 
     [  ] single          5 
     [  ]  cohabiting  6 
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5.  what is the total number of  years you have spent schooling including primary 
school period? Choose the most appropriate answer  
   [  ]  never been to school                  1 
   [  ]  6 years & below (primary)         2  
   [  ]   7 to  12 years (secondary)         3 
   [  ]   13 to  16 years  (tertiary )          4 
   [  ]   above 15 years   (postgraduate) 5        
 
6. Are you in any kind of employment? Please choose one answer. 
  [  ] no     0  
  [  ] yes    1 
 
(If no, Skip 7 & 8) 
 
7. In the place of work that is the main source of your income, what is your employment 
status? Please choose one of the answers below: 
    [  ] full time employee    1 
    [  ] part time employee  2 
    [  ] volunteer                  3 
    [  ] contract staff            4 
    [  ] self employed          5 
    [   ]others specify:………………………………………….6 
 
8. What is your total estimated average monthly earning? Please choose most applicable 
answer below    
   [  ]  below 10,000 Naira          1 
   [  ]  10,000 to 40,000 Naira     2 
   [  ]  41,000 to 80,000 Naira     3 
   [  ]  81,000 to 160,000 Naira   4 
   [  ] 161,000 and above Naira  5 
 
9a. Are you the head of the household? Please answer yes or no: 
 (  ) No  0 
 (  )  Yes 1 
(Skip 9b if the answer is yes) 
  
9b.What is the salary of the head of the household? Please choose from the answers below the 
most appropriate: 
   [  ]  below 10,000 Naira          1 
   [  ]  10,000 to 40,000 Naira     2 
   [  ]  41,000 to 80,000 Naira     3 
   [  ]  81,000 to 160,000 Naira   4 
   [  ] 161,000  and above            5 
 
10. How long have you been on antiretroviral therapy? State in months………….. 
 
 
11. Have you confided your HIV status result in anybody? Please answer yes or no  
  [  ]  No  0 
  [  ] Yes  1 
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12. Of what use are antiretroviral medicines to the body, when used by people living with 
HIV as prescribed? Choose one answer please. 
  [  ]  the medications are used to cure HIV infection                            1                                
  [  ]  the medications cure TB                                                                2 
  [  ]  the medications reduces the number of HIV in the body               3 
  [  ]  do not know                              4 
 
  
14. Describe how you take different ARV medications in line with the pharmacist’s 
instructions?  
(Interviewers to elicit further on the number of the different tablets per dose at 
initiation of therapy and at present, the number of times the respondents take the each 
medication per day, the common side effects and interaction with food)  
(The interviewer will assess the respondents and then mark below the best suited 
for the respondent’s answer. The different tablets may be shown to patients’ to aid 
understanding)  
  [  ] no understanding of the regimen       1   
  [  ] poor understanding of the regimen    2 
  [  ] fair understanding of the regimen      3 
  [  ] good understanding of the regimen   4 
  [  ] excellent understanding of regimen   5 
 
15. How many doses of the medication have you missed? 
(a) in the past 3 days ………………. 
(b) In the last week……………….. 
(c) In the last month. ………………. 
 
16 .Why did you miss doses? 
…………………………………………………………………………………………………
…………………………………………………………………………………………………
…………………………………………………………………………………………………
…………………………………………………………………………………………………
…………………………………………………………………………………………………
………………………………………………………………………………………………… 
 
17. What helps you to remember to take your ARV medications? 
…………………………………………………………………………………………
…………………………………………………………………………………………………
…………………………………………………………………………………………………
…………………………………………………………………………………………………
…………………………………………………………………………………………………
………………………………………………………… 
 
18. Do you feel healthier on or off HIV medications? Choose one answer below: 
  [  ]  on                  1 
  [  ]  off                  2 
  [  ]  don’t know     3 
 
19. When dispensing ARV medications to you, how often does the dispensing pharmacy staff 
advise you (in words) on the medications? Please choose one answer: 
  [  ] never advised verbally  1 
  [  ] occasionally                  2 
  [  ] most of the time            3 
  [  ] every time                     4 
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20. Do you have access to any of the staff in the ARV clinic using the phone? 
  [  ] No               0 
  [  ] Yes              1 
(If No, skip 21) 
 
21. How easy is it to contact an appropriate member of staff of the center by phone, in order 
to seek advice on ARV medications or fix an appointment? Please choose one answer. 
 [  ] Easy                                1 
 [  ] Fairly easy                       2 
 [  ] Difficult                             3 
 [  ] never had  a need to call 4 
 
22. Does the pharmacy run short of ARV medicine and thereby delay the refill of your 
medications at any time since you got enrolled in the program? Please answer yes or no: 
  [  ] No   0 
  [  ]  Rarely 1 
  (  ) sometimes 2 
  (  ) often 3 
  (  ) very often 4 
 
23. (If 1 - 4) How many times within the past 6 months has the pharmacy ran short of anti 
retroviral medications? ………………………………….. 
 
.  
24. Have you ever missed an appointment because you could not afford to pay for 
transportation? 
 [  ]  yes 1 
 [  ]  no 2 
  
  
25. Regarding the way the clinic is conducted, would you advise a close relative who has 
tested positive to HIV to get enrolled in the same center you are attending? Choose one 
answer below: 
 [  ] definitely      1 
 [  ] probably       2 
 [  ] probably not 3 
 [  ] never             4 
 
26. Do you feel that changes should be made in the way the ART clinic is carried out at 
present? 
  (  ) no 0 
  (  ) yes 1 
 
27. (If yes), List 5 changes that should be made in order of their importance 
-------------------------------------------------------------------------------------------------------
-----------------------------------------------------------------------------------------------------------------
-----------------------------------------------------------------------------------------------------------------
-----------------------------------------------------------------------------------------------------------------
-----------------------------------------------------------------------------------------------------------------
-----------------------------------------------------------------------------------------------------------------
-----------------------------------------------------------------------------------------------------------------
-----------------------------------------------------------------------------------------------------------------
------------------------------------------------------------------------ 
 
------------------------- 
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Interviewer & Date 
 
TO BE FILLED BY THE RESEARCHER 
28 Present CD4 count: 
29 CD4 count at initiation of ART: 
30 Was the first 6th Month CD4 count documented within a period covering a week before or 
a week after? 
      [  ] no 
      [  ] yes 
31. Viral load:  
 
32 HAART combination:  …………………,  …………………. 
 
 
 
 
  
 
               
 
 
 
 
 39
UNIVERSITY OF THE WESTERN CAPE 
 
               School of Public Health 
                             Private Bag X17 ● BELLVILLE ● 7535 ● South Africa 
                 Tel: 021- 959 2809, Fax: 021- 959 2872 
 
        
INFORMATION SHEET 
 
AN ASSESSMENT OF ADHERENCE TO HIGHLY ACTIVE ANTIRETROVIRAL THERAPY IN 
ALBERT HORSFALL MEDICAL CENTER: AN ART CENTER IN ABUJA, NIGERIA 
 
This is a study of antiretroviral therapy in Albert Horsfall Medical Center, a primary health medical facility located 
in the Federal Capital City (FCT) – Abuja, Nigeria. This facility is one of the first government owned institution 
that provides antiretroviral therapy to people living with HIV under the federal government national antiretroviral 
therapy program that started in 2002. 
 
The purpose of the study is to provide a good understanding of the ART service as provided by Albert Horsfall 
Medical Center as part of the national program in order that recommendations for the improvemnt of the services 
rendered in the center be profered. Data will be collected through interviews of people living with HIV (PLHIV) 
receiving antiretroviral treatment in the facility. Similarly, measure of CD4 count (a routine blood test that 
estimates the level of immunity) will be performed on each participant PLHIV. The cost of the tests done on 
participants will be part of the research cost and therefore not borne by the participant. Additionally, the 
documents of the clinical and pharmacy records of service will be reviewed by the researcher.  
 
Interviews are to be conducted on one-to-one basis and will arranged after seeking written consent from 
participants and  participation in the study is voluntary. Please note that refusal to participate in this research will 
not in anyway affect  participants status as patients in AHMC; and each participant is free to withdraw from the 
research at anypoint. It important that participants will be made to understand that their actual identity will be kept 
confidential and that any report emanating from the research will be made in such way that the data cannot be 
traced to the participants. 
Finally, please be informed that the study is a course requirement for the award of Masters in Public Health (MPh) 
to the researcher by the university of the Western Cape, South Africa. Your kind cooperation is therfore humbly 
solicited to enable the  student researcher complete his work in good time. Do feel free to contact the reseacher by 
phone or by e-mail for further clarifications or querries regarding the research project. The telephone number and 
the e-mail address are provided below. 
 
Thank y_ou for your time and cooperation. 
___________________ 
C. AKPABIO (DR) 
Student researcher 
Telephone: +234-8029579827 
e-mail: akpabiodot@yahoo.co.uk 
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Annex iii 
 
 
               UNIVERSITY OF THE WESTERN CAPE 
               School of Public Health 
Private Bag X17 ● BELLVILLE ● 7535 ● South Africa 
               Tel: 021- 959 2809, Fax: 021- 959 2872 
 
 
        
 
CONSENT LETTER 
 
Date:  
 
Reseacher (Student): Charles Akpabio (DR) 
UWC Student No: 2402693 
Telephone: +234 9 5236036, mobile: +234 8029579827 , Fax: 
e-mail: akpabiodot@yahoo.co.uk 
 
Institution: ALBERT HORSFALL MEDICAL CENTER 
 
Addressed to : 
 
Place of Interview: 
 
Thank you for accepting to participate in the study. I wish to bring your understanding the purpose and 
the process of the study. 
I am a Masters in Public Health student in the University of the Western Cape, South Africa. As part of 
the course, I am conducting a study of Antiretroviral Drug Therapy (ART) in Albert Horsfall Medical 
Center (AHMC), Abuja, Nigeria. I can be contacted in AHMC. My telephone number is (+ 234(0) 
8029579827), and my e-mail address is akpabiodot@yahoo.co.uk 
 
2. Purpose & Contents of Study: You will be involved in an interview to be conducted for the purpose 
of understanding the ART program in AHMC, from the participants point of view. Data collected from 
these events will be processed to make recommendations for the improvement of the antiretroviral 
therapy program in the center. Your discussions will cover the understanding of the HIV disease, the 
process of receiving the treatment and suggestions on how to improve the program.  
 
3. Interview process: The interview will consist of a one-to-one question and answer session with an 
interviewer using a standardized questionnaire. The time and venue of the interview will be arranged 
with you. Also, blood will be obtained from you for CD4 count and viral load; tests used in monitoring 
the body’s immunity periodically when one is on antiretroviral medications. 
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4. Anonymity of contributors: All sources of information during the exercise will be kept confidential 
and you will be referred to during the entire exercise in your chosen invented name as recorded above. 
I will keep records of participation locked up and will subsequently destroy them after the data has 
been extracted. 
 
5. Things that may affect your willingness to participate: Discussions will be centered on HIV infection 
and its treatment. If you prefer not to answer any question during the interview, there will no negative 
consequences to you. Please be reminded that you are at liberty to withdraw your participation without 
any adverse consequences to you and your treatment in the center will not be affected. 
 
6. Agreement: 
6.1 Please note that acceptance to be interviewed will indicate your consent. 
6.2 Researchers agreement: Your true identity will be kept confidential at all times.  The contents of the 
interview and discussions will be used for data collection as earlier mentioned, however such data may 
be used for published or unpublished research at a further date without further consent. Your identity 
will never be disclosed in any reports.  
6.3 Kindly sign in the space provided below as an indication that you willingly wish to participate in 
the study please. 
Name of the participant: _______________________________________ 
Signature: _______________________  
 
Thank you! 
 
 
------------------------------ 
Charles Akpabio (Dr)  
Date: 
Place: 
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